Our assay development efforts were aimed at multiplexing four proteins associated with Parkinson ́s or Alzheimer ́s disease pathology, i.e. aSyn, DJ-1, t-tau protein and Aβ42, in order to improve diagnostic accuracy by identifying PD pathology or by excluding AD pathology. This evidence concerns the gene PARK7 and early-onset autosomal dominant Alzheimer disease.